within Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CD04_Corticorelin;

model Corticorelin
  extends Pharmacolibrary.Drugs.ATC.V.V04CD04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V04CD04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Corticorelin, also known as ovine corticotropin-releasing hormone (oCRH), is a synthetic peptide analog of the naturally occurring hypothalamic peptide corticotropin-releasing hormone. It is mainly used as a diagnostic agent to differentiate between pituitary (Cushing's disease) and ectopic sources of adrenocorticotropic hormone (ACTH) in the evaluation of Cushing's syndrome. Corticorelin is approved for human use as a diagnostic aid, not for therapeutic purposes.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetics in healthy adults, as no published population PK study is available. Most dosing is by single intravenous administration for diagnostic purposes.</p><h4>References</h4><ol><li><p>Moliterno, JA, et al., &amp; Pannullo, SC (2009). Corticorelin acetate injections for the treatment of peritumoral brain edema. <i>Expert opinion on investigational drugs</i> 18(9) 1413–1419. DOI:<a href=&quot;https://doi.org/10.1517/13543780903190689&quot;>10.1517/13543780903190689</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19678803/&quot;>https://pubmed.ncbi.nlm.nih.gov/19678803</a></p></li><li><p>Angst, MS, et al., &amp; Shafer, SL (1998). Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans. <i>Clinical pharmacology and therapeutics</i> 64(5) 499–510. DOI:<a href=&quot;https://doi.org/10.1016/S0009-9236(98)90133-3&quot;>10.1016/S0009-9236(98)90133-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9834042/&quot;>https://pubmed.ncbi.nlm.nih.gov/9834042</a></p></li><li><p>Chrousos, GP, et al., &amp; Loriaux, DL (1985). Corticotropin releasing factor: basic studies and clinical applications. <i>Progress in neuro-psychopharmacology &amp; biological psychiatry</i> 9(4) 349–359. DOI:<a href=&quot;https://doi.org/10.1016/0278-5846(85)90187-3&quot;>10.1016/0278-5846(85)90187-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2999871/&quot;>https://pubmed.ncbi.nlm.nih.gov/2999871</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Corticorelin;
